common.skip_to_content
USE CODE MUNCHMAKERS FOR 10% OFF YOUR FIRST ORDER (650) 955-1836 MON–FRI 8AM–5PM PT | REQUEST A CALLBACK
USE MUNCHMAKERS FOR 10% OFF YOUR FIRST ORDER

Colorado Audit Reveals Gaps in Cannabis Testing Oversight

State regulators failed to prevent contaminated products from reaching consumers, auditors found

Colorado's cannabis regulatory system has failed to adequately protect consumers from potentially contaminated products, according to a state audit released this week that found significant delays in enforcement and insufficient oversight of testing laboratories.

The audit, conducted by the Colorado Office of the State Auditor, identified multiple breakdowns in the state's testing and compliance framework. Regulators took too long to act on failed test results, allowed products to reach shelves despite quality concerns, and lacked clear protocols for handling contaminated inventory.

"The current system creates gaps where unsafe products can slip through," the audit stated, pointing to cases where cannabis products flagged for contaminants remained in circulation for weeks before regulators intervened.

Testing Lab Problems

The audit found that Colorado's Marijuana Enforcement Division (MED) does not adequately verify the accuracy of testing laboratories. While the state requires all cannabis products to undergo testing for pesticides, heavy metals, and microbial contaminants, auditors discovered that labs face minimal oversight and inconsistent quality checks.

Colorado operates under a "seed-to-sale" tracking system meant to monitor all cannabis products from cultivation through retail. But the audit revealed that this system fails to flag problematic test results quickly enough to prevent sales. In some cases, products that failed initial testing were retested at different laboratories and eventually passed, raising questions about testing consistency across facilities.

The state licenses 21 cannabis testing laboratories, but auditors found that MED conducts proficiency testing on only a fraction of these facilities each year. This limited oversight means laboratories operating with substandard procedures can continue testing products without detection.

Enforcement Delays

When contaminated products are identified, Colorado regulators take an average of 47 days to complete investigations and issue recalls, the audit found. During this window, products often remain available for purchase.

The audit cited specific instances where MED knew about failed test results but did not immediately quarantine affected inventory. Instead, regulators relied on licensees to voluntarily remove products, a process that auditors described as "insufficiently rigorous."

Colorado's cannabis industry generated $1.5 billion in sales last year, making regulatory oversight critical for consumer safety and market integrity. The state collects roughly $400 million annually in cannabis tax revenue.

Industry Response

Several cannabis businesses told auditors that unclear guidance from MED created confusion about testing requirements and recall procedures. Some licensees reported receiving conflicting instructions from different regulators about how to handle failed tests.

The Colorado Cannabis Chamber of Commerce has not yet issued a formal response to the audit findings. However, industry advocates have long called for clearer testing standards and more consistent enforcement across the state's regulatory framework.

What Comes Next

The audit included 11 recommendations for MED, including developing faster response protocols for failed tests, implementing regular proficiency testing for all laboratories, and creating a public database of recalled products.

MED accepted all 11 recommendations and committed to implementing changes by June 2025. The agency told auditors it plans to hire additional compliance staff and upgrade its tracking systems to flag problematic test results more quickly.

Colorado lawmakers may also consider legislative changes when the General Assembly reconvenes in January. Several legislators have indicated interest in strengthening testing requirements and increasing penalties for laboratories that provide inaccurate results.

The audit arrives as other states look to Colorado's regulatory model for guidance. The findings may influence how newer cannabis markets structure their testing and compliance systems, particularly states that recently launched adult-use programs.


This article is based on original reporting by mjbizdaily.com.

More from David Okonkwo